Xiangyu Medical Co. Ltd. A (688626) - Total Assets
Based on the latest financial reports, Xiangyu Medical Co. Ltd. A (688626) holds total assets worth CN¥3.27 Billion CNY (≈ $478.83 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 688626 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Xiangyu Medical Co. Ltd. A - Total Assets Trend (2017–2024)
This chart illustrates how Xiangyu Medical Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. Check 688626 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Xiangyu Medical Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2024)
Xiangyu Medical Co. Ltd. A's total assets of CN¥3.27 Billion consist of 39.0% current assets and 61.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 25.4% |
| Accounts Receivable | CN¥82.95 Million | 2.8% |
| Inventory | CN¥238.21 Million | 8.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥216.89 Million | 7.4% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Xiangyu Medical Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 688626 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Xiangyu Medical Co. Ltd. A's current assets represent 39.0% of total assets in 2024, a decrease from 65.0% in 2017.
- Cash Position: Cash and equivalents constituted 25.4% of total assets in 2024, up from 4.7% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 8.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 8.1% of total assets.
Xiangyu Medical Co. Ltd. A Competitors by Total Assets
Key competitors of Xiangyu Medical Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
|
Shenzhen Lifotronic Technology Co
SHG:688389
|
China | CN¥2.53 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
Xiangyu Medical Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.26 | 1.81 | 3.36 |
| Quick Ratio | 0.99 | 1.43 | 2.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥266.92 Million | CN¥507.94 Million | CN¥471.38 Million |
Xiangyu Medical Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Xiangyu Medical Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.05 |
| Latest Market Cap to Assets Ratio | 0.38 |
| Asset Growth Rate (YoY) | 13.0% |
| Total Assets | CN¥2.93 Billion |
| Market Capitalization | $1.13 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Xiangyu Medical Co. Ltd. A's assets below their book value (0.38x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Xiangyu Medical Co. Ltd. A's assets grew by 13.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Xiangyu Medical Co. Ltd. A (2017–2024)
The table below shows the annual total assets of Xiangyu Medical Co. Ltd. A from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.93 Billion ≈ $428.44 Million |
+12.95% |
| 2023-12-31 | CN¥2.59 Billion ≈ $379.31 Million |
+9.46% |
| 2022-12-31 | CN¥2.37 Billion ≈ $346.52 Million |
+8.50% |
| 2021-12-31 | CN¥2.18 Billion ≈ $319.38 Million |
+122.36% |
| 2020-12-31 | CN¥981.53 Million ≈ $143.63 Million |
+35.56% |
| 2019-12-31 | CN¥724.07 Million ≈ $105.95 Million |
+28.95% |
| 2018-12-31 | CN¥561.49 Million ≈ $82.16 Million |
+39.79% |
| 2017-12-31 | CN¥401.67 Million ≈ $58.78 Million |
-- |
About Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment… Read more